Literature DB >> 27906607

Wald tests for variance-adjusted equivalence assessment with normal endpoints.

Yue-Ming Chen1, Yu-Ting Weng2, Xiaoyu Dong2, Yi Tsong2.   

Abstract

Equivalence tests may be tested with mean difference against a margin adjusted for variance. The justification of using variance adjusted non-inferiority or equivalence margin is for the consideration that a larger margin should be used with large measurement variability. However, under the null hypothesis, the test statistic does not follow a t-distribution or any well-known distribution even when the measurement is normally distributed. In this study, we investigate asymptotic tests for testing the equivalence hypothesis. We apply the Wald test statistic and construct three Wald tests that differ in their estimates of variances. These estimates of variances include the maximum likelihood estimate (MLE), the uniformly minimum variance unbiased estimate (UMVUE), and the constrained maximum likelihood estimate (CMLE). We evaluate the performance of these three tests in terms of type I error rate control and power using simulations under a variety of settings. Our empirical results show that the asymptotic normalized tests are conservative in most settings, while the Wald tests based on ML- and UMVU-method could produce inflated significance levels when group sizes are unequal. However, the Wald test based on CML-method provides an improvement in power over the other two Wald tests for medium and small sample size studies.

Keywords:  Constrained maximum likelihood estimate; Wald tests; equivalence tests

Mesh:

Year:  2016        PMID: 27906607     DOI: 10.1080/10543406.2016.1265542

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  4 in total

1.  Commentary on "Statistical Approaches to Assess Biosimilarity from Analytical Data" by Burdick et al [1].

Authors:  Yi Tsong; Qi Xia; Yu-Ting Weng
Journal:  AAPS J       Date:  2016-10-05       Impact factor: 4.009

2.  An evaluation roadmap for critical quality attributes from tier 1 in analytical similarity assessment.

Authors:  Kejian Wu; Haitao Pan; Chen Li; Qingbo Zhao; Ling Wang; Jielai Xia
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

3.  Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells.

Authors:  Tomokazu S Sumida; Shai Dulberg; Jonas C Schupp; Matthew R Lincoln; Helen A Stillwell; Pierre-Paul Axisa; Michela Comi; Avraham Unterman; Naftali Kaminski; Asaf Madi; Vijay K Kuchroo; David A Hafler
Journal:  Nat Immunol       Date:  2022-03-17       Impact factor: 31.250

4.  Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.

Authors:  David Hafler; Tomokazu Sumida; Shai Dulberg; Jonas Schupp; Helen Stillwell; Pierre-Paul Axisa; Michela Comi; Matthew Lincoln; Avraham Unterman; Naftali Kaminski; Asaf Madi; Vijay Kuchroo
Journal:  Res Sq       Date:  2021-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.